Anion-Dependent Stimulation of CYP3A4 Monooxygenase

Biochemistry

Volumn 54, Issue 26, 2015, Pages 4083-4096

  Sevrioukova, Irina F ^a   Poulos, Thomas L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; CATALYST ACTIVITY; IONIC STRENGTH; NEGATIVE IONS; PHOSPHOLIPIDS; PROTEINS;

ANIONIC PHOSPHOLIPIDS; COMPARATIVE ANALYSIS; COMPLEX MECHANISMS; CONCENTRATION-DEPENDENT MANNERS; CYTOCHROME P450 REDUCTASE; MICROSOMAL MEMBRANES; NEGATIVELY CHARGED; PROTEIN INTERACTION;

IONS;

ANION; CITRIC ACID; CYTOCHROME P450 3A4; CYTOCHROME P450 REDUCTASE; ORGANIC COMPOUND; PHOSPHOLIPID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNSPECIFIC MONOOXYGENASE; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; PROGESTERONE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CATALYSIS; CRYSTAL STRUCTURE; CRYSTALLIZATION; ELECTRON TRANSPORT; ENZYME ACTIVE SITE; IONIC STRENGTH; MICROSOME MEMBRANE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN INTERACTION; REDUCTION KINETICS; STEADY STATE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; X RAY DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVATION; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; X RAY CRYSTALLOGRAPHY;

ANIONS; BINDING SITES; CITRATES; CRYSTALLOGRAPHY, X-RAY; CYTOCHROME P-450 CYP3A; ENZYME ACTIVATION; HUMANS; MODELS, MOLECULAR; OXIDATION-REDUCTION; PROGESTERONE;

EID: 84936745713     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b00510     Document Type: Article

References (61)

1. Guengerich, F. P. (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism Annu. Rev. Pharmacol. Toxicol. 39, 1-17
2. Wienkers, L. C. and Heath, T. G. (2005) Predicting in vivo drug interactions from in vitro drug discovery data Nat. Rev. Drug Discovery 4, 825-833
3. Ueng, Y. F., Kuwabara, T., Chun, Y. J., and Guengerich, F. P. (1997) Cooperativity in oxidations catalyzed by cytochrome P450 3A4 Biochemistry 36, 370-381
4. Atkins, W. M., Wang, R. W., and Lu, A. Y. (2001) Allosteric behavior in cytochrome P450-dependent in vitro drug-drug interactions: a prospective based on conformational dynamics Chem. Res. Toxicol. 14, 338-347
5. Hutzler, J. M. and Tracy, T. S. (2002) Atypical kinetic profiles in drug metabolism reactions Drug. Metab. Dispos. 30, 355-362
6. Ekroos, M. and Sjogren, T. (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4 Proc. Natl. Acad. Sci. U.S.A. 103, 13682-13687
7. Sevrioukova, I. F. and Poulos, T. L. (2013) Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues Biochemistry 52, 4474-4481
8. Williams, P. A., Cosme, J., Vinkovic, D. M., Ward, A., Angove, H. C., Day, P. J., Vonrhein, C., Tickle, I. J., and Jhoti, H. (2004) Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone Science 305, 683-686
9. Sevrioukova, I. F. and Poulos, T. L. (2012) Structural and mechanistic insights into the interaction of cytochrome P4503A4 with bromoergocryptine, a type I ligand J. Biol. Chem. 287, 3510-3517
10. Zhao, Y., White, M. A., Muralidhara, B. K., Sun, L., Halpert, J. R., and Stout, C. D. (2006) Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction J. Biol. Chem. 281, 5973-5981
11. Denisov, I. G., Shih, A. Y., and Sligar, S. G. (2012) Structural differences between soluble and membrane bound cytochrome P450s J. Inorg. Biochem. 108, 150-158
12. Harlow, G. R. and Halpert, J. R. (1998) Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics Proc. Natl. Acad. Sci. U.S.A. 95, 6636-6641
13. Sevrioukova, I. F. and Poulos, T. L. (2010) Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir Proc. Natl. Acad. Sci. U.S.A. 107, 18422-18427
14. Shen, A. L., Porter, T. D., Wilson, T. E., and Kasper, C. B. (1989) Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis J. Biol. Chem. 264, 7584-7589
15. Djordjevic, S., Roberts, D. L., Wang, M., Shea, T., Camitta, M. G., Masters, B. S., and Kim, J. J. (1995) Crystallization and preliminary X-ray studies of NADPH-cytochrome P450 reductase Proc. Natl. Acad. Sci. U.S.A. 92, 3214-3218
16. Collaborative computational project number 4 (1994) The CCP4 suite programs for protein crystallography Acta Crystallogr., Sect. D: Biol. Crystallogr. 50, 760-763
17. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development of Coot Acta Crystallogr., Sect. D: Biol. Crystallogr. 66, 486-501
18. Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 66, 213-221
19. Sohl, C. D., Cheng, Q., and Guengerich, F. P. (2009) Chromatographic assays of drug oxidation by human cytochrome P450 3A4 Nat. Protoc. 4, 1252-1257
20. Imaoka, S., Imai, Y., Shimada, T., and Funae, Y. (1992) Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity Biochemistry 31, 6063-6069
21. Ingelman-Sundberg, M., Hagbjork, A. L., Ueng, Y. F., Yamazaki, H., and Guengerich, F. P. (1996) High rates of substrate hydroxylation by human cytochrome P450 3A4 in reconstituted membranous vesicles: influence of membrane charge Biochem. Biophys. Res. Commun. 221, 318-322
22. Kim, K.-H., Aln, T., and Yun, C.-H. (2003) Membrane properties induced by anionic phospholipids and phosphatidylethanolamine are critical for the membrane binding and catalytic activity of human cytochrome P450 3A4 Biochemistry 42, 15377-15387
23. Gemzik, B., Halvorson, M. R., and Parkinson, A. (1990) Pronounced and differential effects of ionic strength and pH on testosterone oxidation by membrane-bound and purified forms of rat liver microsomal cytochrome P-450 J. Steroid Biochem. 35, 429-440
24. Denisov, I. G., Baas, B. J., Grinkova, Y. V., and Sligar, S. G. (2007) Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation J. Biol. Chem. 282, 7066-7076
25. 5 J. Biol. Chem. 271, 27438-27444
26. Guengerich, F. P. and Johnson, W. W. (1997) Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems Biochemistry 36, 14741-14750
27. Farooq, Y. and Roberts, G. C. (2010) Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4 Biochem. J. 432, 485-493
28. Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S., and Kim, J. J. (1997) Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes Proc. Natl. Acad. Sci. U.S.A. 94, 8411-8416
29. Masters, B. S., Bilimoria, M. H., Kamin, H., and Gibson, Q. H. (1965) The mechanism of 1- and 2-electron transfers catalyzed by reduced triphosphopyridine nucleotide-cytochrome c reductase J. Biol. Chem. 240, 4081-4088
30. Masters, B. S., Kamin, H., Gibson, Q. H., and Williams, C. H., Jr. (1965) Studies on the mechanism of microsomal triphosphopyridine nucleotide-cytochrome c reductase J. Biol. Chem. 240, 921-931
31. 5 reductases Biochemistry 13, 1701-1710
32. Iyanagi, T. and Mason, H. S. (1973) Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase Biochemistry 12, 2297-2308
33. Yasukochi, Y., Peterson, J. A., and Masters, B. S. (1979) NADPH-cytochrome c (P-450) reductase. Spectrophotometric and stopped flow kinetic studies on the formation of reduced flavoprotein intermediates J. Biol. Chem. 254, 7097-7104
34. Vermilion, J. L., Ballou, D. P., Massey, V., and Coon, M. J. (1981) Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase J. Biol. Chem. 256, 266-277
35. Oprian, D. D. and Coon, M. J. (1982) Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH J. Biol. Chem. 257, 8935-8944
36. Bhattacharyya, A. K., Lipka, J. J., Waskell, L., and Tollin, G. (1991) Laser flash photolysis studies of the reduction kinetics of NADPH:cytochrome P-450 reductase Biochemistry 30, 759-765
37. Gutierrez, A., Lian, L. Y., Wolf, C. R., Scrutton, N. S., and Roberts, G. C. (2001) Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains Biochemistry 40, 1964-1975
38. Gutierrez, A., Paine, M., Wolf, C. R., Scrutton, N. S., and Roberts, G. C. (2002) Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding Biochemistry 41, 4626-4637
39. Gutierrez, A., Grunau, A., Paine, M., Munro, A. W., Wolf, C. R., Roberts, G. C., and Scrutton, N. S. (2003) Electron transfer in human cytochrome P450 reductase Biochem. Soc. Trans. 31, 497-501
40. 5, and iron-EDTA reductase activities of liver microsomal NADPH-cytochrome c reductase Ann. N.Y. Acad. Sci. 212, 428-448
41. Black, S. D., French, J. S., Williams, C. H., Jr., and Coon, M. J. (1979) Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450LM Biochem. Biophys. Res. Commun. 91, 1528-1535
42. Black, S. D. and Coon, M. J. (1982) Structural features of liver microsomal NADPH-cytochrome P-450 reductase. Hydrophobic domain, hydrophilic domain, and connecting region J. Biol. Chem. 257, 5929-5938
43. Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R. A., Rettie, A. E., Gonzalez, F. J., and Tracy, T. S. (1998) Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites Biochemistry 37, 4137-4147
44. Roberts, A. G., Yang, J., Halpert, J. R., Nelson, S. D., Thummel, K. T., and Atkins, W. M. (2011) The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4 Biochemistry 50, 10804-10818
45. Davydov, D. R., Rumfeld, J. A. O., Sineva, E. V., Fernando, H., Davydova, N. Y., and Halpert, J. R. (2012) Peripheral ligand binding site in cytochrome P450 3A4 located with fluorescence resonance energy transfer (FRET) J. Biol. Chem. 287, 6797-6809
46. Denisov, I. G., Grinkova, Y. V., Baylon, J. L., Tajkhorshid, E., and Sligar, S. G. (2015) Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer Biochemistry 54, 2227-2239
47. Black, S. D., Martin, S. T., and Smith, C. A. (1994) Membrane topology of liver microsomal cytochrome P450 2B4 determined via monoclonal antibodies directed to the halt-transfer signal Biochemistry 33, 6945-6951
48. Shank-Retzlaff, M. L., Raner, G. M., Coon, M. J., and Sligar, S. G. (1998) Membrane topology of cytochrome P450 2B4 in Langmuir-Blodgett monolayers Arch. Biochem. Biophys. 359, 82-88
49. Headlam, M. J., Wilce, M. C., and Tuckey, R. C. (2003) The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane Biochim. Biophys. Acta 1617, 96-108
50. Berka, K., Hendrychova, T., Anzenbacher, P., and Otyepka, M. (2011) Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site J. Phys. Chem. A 115, 11248-11255
51. Cojocaru, V., Balali-Mood, K., Sansom, M. S., and Wade, R. C. (2011) Structure and dynamics of the membrane-bound cytochrome P450 2C9 PLoS Comput. Biol. 7, e1002152
52. Berka, K., Paloncyova, M., Anzenbacher, P., and Otyepka, M. (2013) Behavior of human cytochromes P450 on lipid membranes J. Phys. Chem. B 117, 11556-11564
53. Monk, B. C., Tomasiak, T. M., Keniya, M. V., Huschmann, F. U., Tyndall, J. D., O'Connell, J. D., III, Cannon, R. D., McDonald, J. G., Rodriguez, A., Finer-Moore, J. S., and Stroud, R. M. (2014) Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer Proc. Natl. Acad. Sci. U.S.A. 111, 3865-3870
54. Davydov, D. R., Davydova, N. Y., Sineva, E. V., and Halpert, J. R. (2015) Interactions among cytochromes P450 in microsomal membranes: Oligomerization of cytochromes P450 3A4, 3A5 and 2E1 and its functional consequences J. Biol. Chem. 290, 3850-3864
55. Davydov, D. R., Davydova, N. Y., Sineva, E. V., Kufareva, I., and Halpert, J. R. (2013) Pivotal role of P450-P450 interactions in CYP3A4 allostery: the case of alpha-naphthoflavone Biochem. J. 453, 219-230
56. Voznesensky, A. I. and Schenkman, J. B. (1992) Inhibition of cytochrome-P450 reductase by polyols has an electrostatic nature Eur. J. Biochem. 210, 741-746
57. Voznesensky, A. I. and Schenkman, J. B. (1992) The cytochrome P450 2B4-NADPH cytochrome P450 reductase electron transfer complex is not formed by charge-pairing J. Biol. Chem. 267, 14669-14676
58. Voznesensky, A. I. and Schenkman, J. B. (1994) Quantitative analyses of electrostatic interactions between NADPH-cytochrome P450 reductase and cytochrome P450 enzymes J. Biol. Chem. 269, 15724-15731
59. 2-terminal region of rabbit CYP2E1 is not essential for interaction with NADPH-cytochrome P450 reductase Biochem. Biophys. Res. Commun. 203, 156-161
60. 5 and phospholipid with unsaturated fatty acids Arch. Biochem. Biophys. 291, 231-240
61. Maenpaa, J., Hall, S. D., Ring, B. J., Strom, S. C., and Wrighton, S. A. (1998) Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone Pharmacogenetics 8, 137-155